The European women’s health market is valued at over $917 million, and is estimated to grow to $1.1 billion by 2017 due to recovery of the digital breast imaging, OB/GYN ultrasound imaging and female sterilization segments. Implementation of national breast screening programs by European health authorities is expected to counteract the negative effects of the global economic crisis, resulting in double-digit growth of the European digital mammography market by 2017. The report states that in 2010, the OB/GYN ultrasound accounted for more than one-quarter of the total European women’s health market and will continue to grow due to technological advances from GE, Siemens and Philips such as 3D/4D real-time imaging. These new systems allow for easier detection of fetal abnormalities and high-risk pregnancies.

 Learn More in iData Research’s New Press Release